US equities |
INTC $65.33 ▼-29.04% AMZN $237.33 ▼-2.65% MU $892.71 ▼-4.45% NVDA $207.21 ▼-3.02% SNDK $1,208.94 ▼-9.11% GOOGL $280.12 ▼-1.30% AMD $514.17 ▼-9.22% TSLA $397.24 ▼-1.50%
FinancialContent

Immix Biopharma, Inc. - Common Stock (NQ:IMMX)

7.720 -0.260 (-3.26%)
Delayed Quote Updated: 10:13 AM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immix Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Immix Biopharma Announces 16th Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
From Immix Biopharma, Inc.
Via GlobeNewswire
News headline image
ImmixBio Ships Tislelizumab for Patient Dosing in its Combination Clinical Trial with IMX-110 in Advanced Solid Tumors
From Immix Biopharma, Inc.
Via GlobeNewswire
News headline image
Dow Drops Over 300 Points After Fed Raises Key Overnight Interest Rate By 50 bps ↗
U.S. stocks turned lower toward the end of trading, after the Federal Reserve announced its policy decision. 
Via Benzinga
News headline image
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. 
Via Benzinga
News headline image
Dow Surges Over 100 Points; Charter Communications Shares Slide ↗
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Wednesday 
Via Benzinga
News headline image
Why Immix Biopharma Shares Are Surging Today? ↗
Immix Biopharma Inc (NASDAQ: IMMX) announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 (formerly HBI0101). 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
From Immix Biopharma, Inc.
Via GlobeNewswire
News headline image
Immix Biopharma in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma (71% Complete Responses) and AL Amyloidosis (100% Complete Responses)
From Immix Biopharma, Inc.
Via GlobeNewswire
News headline image
ImmixBio Releases and Ships Scaled-Up GMP Batches of IMX-110 for Clinical Trial Patient Dosing
From Immix Biopharma, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 111 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 53 companies reached new 52-week lows. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
  
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 120 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  During Tuesday's session, 78 companies made new 52-week lows. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
121 Stocks That Hit Their 52-Week Low ↗
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows. 
Via Benzinga
News headline image
38 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma... 
Via Benzinga
News headline image
Dow Brushes Off Rate Hike Fears, Microsoft Warning ↗
Investors are attempting to brush off comments from Federal Reserve Vice President Lael Brainard, which reignited rate hike concerns. 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
74 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Good morning, investors! It's time to start another day of trading with the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
News headline image
53 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
24 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) rose 42.2% to $2.63 in pre-market trading after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
77 Biggest Movers From Yesterday ↗
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >